Cancer chemoprevention: successes and failures (Q26852358)

K. Colbert Maresso

series ordinal

2

1 reference

E. Hawk

series ordinal

3

1 reference

language of work or name

1 reference

January 2013

1 reference

1 reference

59

1 reference

PubMed

page(s)

94-101

1 reference

PubMed

issue

1

1 reference

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Dietary vitamin a and human lung cancer

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Dietary habits and lung cancer risk

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Design of the Prostate Cancer Prevention Trial (PCPT).

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

1 reference

7 January 2021

Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Dietary vitamin A and risk of cancer in the Western Electric study

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

SELECT: the selenium and vitamin E cancer prevention trial

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Can dietary beta-carotene materially reduce human cancer rates?

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

The safety and efficacy of celecoxib in children with familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

The influence of finasteride on the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Exemestane for breast-cancer prevention in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Ingenol mebutate gel for actinic keratosis

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

A review of epidemiologic evidence that carotenoids reduce the risk of cancer

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Accelerated approval of oncology products: the food and drug administration experience

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021

Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview

1 reference

https://api.crossref.org/works/10.1373%2FCLINCHEM.2012.185389

7 January 2021